| Related Information: |
| The United Kingdom: Ulipristal acetate 5mg (Esmya): further restrictions due to ... Posted 2021-02-19 |
| European Union: Ulipristal acetate for uterine fibroids: EMA recommends restrict... Posted 2020-11-14 |
| Singapore: Voluntary withdrawal of Esmya (ulipristal acetate) Tablet 5mg by Zuel... Posted 2020-10-10 |
| Canada: FIBRISTAL (ulipristal acetate tablets, 5 mg): Voluntary withdrawal in Ca... Posted 2020-10-05 |
| Canada: Recall: Fibristal 5mg Tablet Posted 2020-09-29 |
| Singapore: Temporary suspension of sales of Esmya (ulipristal acetate) tablet 5 ... Posted 2020-09-19 |
| Canada: Health Canada reviews safety of drug Fibristal (ulipristal acetate) agai... Posted 2020-09-17 |
| European Union: PRAC recommends revoking marketing authorisation of ulipristal a... Posted 2020-09-05 |
| 台灣：回收恩惜膜5毫克錠劑Esmya 5mg tablets (Chinese only) Posted 2020-04-14 |
| Singapore: Temporary suspension of the sales of Esmya (ulipristal acetate) Table... Posted 2020-04-03 |
| Singapore: Temporary suspension of the sales of Esmya (ulipristal acetate) Table... Posted 2020-03-27 |
| The United Kingdom: Class 2 Medicines Recall: Esmya 5mg tablets Posted 2020-03-19 |
| The United Kingdom: Esmya (ulipristal acetate): suspension of the licence due to... Posted 2020-03-19 |
| EMA recommended the suspension of ulipristal acetate for uterine fibroids during... Posted 2020-03-16 |
| European Union: Suspension of ulipristal acetate for uterine fibroids during ong... Posted 2020-03-14 |
| Singapore: Risk of serious liver injury with Esmya (ulipristal acetate) Posted 2019-09-13 |
| Singapore: Esmya (ulipristal acetate) and risk of serious liver injury Posted 2019-04-04 |
| Canada: Health Canada safety review finds possible link between Fibristal and ri... Posted 2019-01-12 |
| Canada: Summary Safety Review - Fibristal (5 mg ulipristal acetate) - Assessing ... Posted 2018-09-11 |
| United Kingdom: Esmya (ulipristal acetate) and risk of serious liver injury: new... Posted 2018-08-25 |
| Singapore: Important safety update on risk of liver injury with Esmya (uliprista... Posted 2018-06-12 |
| European Union: Esmya: new measures to minimise risk of rare but serious liver i... Posted 2018-06-02 |
| European Union: PRAC recommends new measures to minimise risk of rare but seriou... Posted 2018-05-19 |
| European Union: Women taking Esmya (ulipristal) for uterine fibroids to have reg... Posted 2018-04-14 |
| Canada: Health Canada to conduct review of a new potential safety risk of Fibris... Posted 2018-03-16 |
| The United Kingdom: Esmya (ulipristal acetate) for uterine fibroids: do not init... Posted 2018-03-09 |
| Singapore: Important safety update on potential risk of liver injury with Esmya ... Posted 2018-02-21 |
| The United Kingdom: Esmya: no new treatment courses prescribed until further not... Posted 2018-02-20 |
| European Union: Women taking Esmya for uterine fibroids to have regular liver te... Posted 2018-02-10 |
| European Union : EMA starts review of Esmya for uterine fibroids - Review trigge... Posted 2017-12-02 |
